Dr Iddings Survivors’ Reunion 2014! Thursday December 4 6:30pm to 9:30pm

October 27, 2014 by  
Filed under Uncategorized

Comments Off on Dr Iddings Survivors’ Reunion 2014! Thursday December 4 6:30pm to 9:30pm

1888956_711496222259734_3985526773068510645_o

Dr Iddings Has Moved

Comments Off on Dr Iddings Has Moved

Dr Iddings Has Moved

Dr Iddings 5-year Patient Choice Award!

November 7, 2013 by  
Filed under Awards

Comments Off on Dr Iddings 5-year Patient Choice Award!

Dr Iddings 5 Year Patient Choice Award

2011 Most Compassionate Doctor Award

June 26, 2012 by  
Filed under Awards

Comments Off on 2011 Most Compassionate Doctor Award

The 2011 patient reviews have been totaled, and you were selected by your patients for the Compassionate Doctor Recognition!

Congratulations Dr. Iddings,

Treating patients, not just the disease, is what you excel at, and your patients appreciate the kindness you have dispensed along with your medical care.

This award is based on reviews written by hundreds of thousands of patients. While physicians generally receive positive feedback from their patients, only a select few receive praise about the compassion that accompanied their care. In fact, of the nation’s 720,000 active physicians, less than 3% were accorded this honor by their patients in 2011.

Congratulations on perhaps the most important recognition a doctor can receive, the recognition of their patients.

Taylor Green
1-866-964-0866 x2
tgreen@americanregistry.com

All About Robotic Surgery – Spotlight Feature – Dr. Iddings

January 15, 2012 by  
Filed under Cancer in the news, Publications

Comments Off on All About Robotic Surgery – Spotlight Feature – Dr. Iddings

Welcome to our Fourth Issue of

All About Robotic Surgery – Feature Spotlight

Our “Spotlight Feature” Series

in which we will highlight;

Dr. Douglas M. Iddings FACS
Fellowship Trained Surgical Oncologist

Special Expertise:
Endocrine Surgery; Thyroid, Parathyroid, Adrenal.
Gynecologic Oncology; Head and Neck Squamous cell carcinoma.
Hepatobiliary Surgery; Liver, Pancreas, Melanoma.
Robotic Oncologic Surgery; Soft Tissue Cancer Sarcoma.
Surgical Oncology

CLICK HERE TO READ THE SPOTLIGHT FEATURE –

DR. IDDINGS AT ALLABOUTROBOTICSURGERY.COM

2011 Patient’s Choice Award

December 9, 2011 by  
Filed under Awards

Comments Off on 2011 Patient’s Choice Award

Patient’s Choice Award

Nov 1, 2011

Douglas M Iddings, DO
8384 Holly Rd
Grand Blanc, MI, 48439-1974

Dear Dr. Iddings:

Congratulations! You have once again been recognized as a Patients’ Choice physician.

Every month, more than 200,000 patients across the U.S. provide online feedback about their doctor experiences. They rate various components of the care they receive, such as bedside manner, doctor-patient face time, follow-up care, ease of appointment setting, courtesy of office staff, and they also share their overall opinions.

Over the course of 2011, hundreds of thousands of patient reviews were written and shared. While physicians generally receive positive feedback from their patients, only a select few consistently receive rave reviews. Of those with high praise, only physicians like yourself – with near perfect scores – have been voted by their patients for this honor.

In fact, of the nation’s 720,000 active physicians, less than 6 percent were accorded this honor by their patients in 2010.

You are, indeed, the Patients’ Choice; a physician so highly regarded by their patients that they feel the need to talk to others about the positive influence of your work.

This notation of your distinction as a 2011 Patients’ Choice physician will be prominently displayed in your Profile on a broad collection of web sites, including PatientsChoice, Vitals, Google, and a variety of Managed Care sites. More than 500,000 people view these websites on a daily basis.

To ensure all aspects of your profile are correct, please go to www.vitals.com and click “login: physician” in the upper right hand corner of the site; there you will be able to log in using your previously registered email and password, or if you have not previously registered you will be able to do so by clicking “get started.”

Congratulations once again on this outstanding distinction.

Sincerely,

Erika Boyer
Vice President, Consumer Research

 

 

 

 

 

 

 

 

 

The “Patients’ Choice” award is tabulated by MDx Medical, Inc.

MDx Medical, Inc. 1200 Wall Street West, Lyndhurst, NJ 07071 T. 201.624.2480 F. 201.438.4555

CNN Airport Radio Interview with Dr. Douglas Iddings

May 21, 2011 by  
Filed under Uncategorized

Comments Off on CNN Airport Radio Interview with Dr. Douglas Iddings

CNN Interview
CNN Airport Radio Interview with Dr. Douglas Iddings
Click on the CNN logo to listen to the interview.

2010 Most Compationate Doctor

May 1, 2011 by  
Filed under Awards

Comments Off on 2010 Most Compationate Doctor

The 2010 patient reviews have been totaled, and you were selected by your patients for the Compassionate Doctor Recognition!

Congratulations Dr. Iddings,

Treating patients, not just the disease, is what you excel at, and your patients appreciate the kindness you have dispensed along with your medical care.

This award is based on reviews written by hundreds of thousands of patients. While physicians generally receive positive feedback from their patients, only a select few receive praise about the compassion that accompanied their care. In fact, of the nation’s 720,000 active physicians, less than 3% were accorded this honor by their patients in 2010.

Congratulations on perhaps the most important recognition a doctor can receive, the recognition of their patients.

Taylor Green
1-866-964-0866 x2
tgreen@americanregistry.com

ASCO.org News Releases

February 28, 2011 by  
Filed under Cancer in the news

Comments Off on ASCO.org News Releases

ASCO.org Recent News

    www.Cancer.gov News Releases

    February 20, 2011 by  
    Filed under Cancer in the news

    Comments Off on www.Cancer.gov News Releases

    http://www.cancer.gov/newscenter
    1. Szent-Györgyi Prize to honor NCI’s Douglas R. Lowy and John T. Schiller -

      Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute will receive the 2018 Szent-Gyorgyi Prize for Progress in Cancer Research for the development of HPV vaccines.

    2. Norman Sharpless sworn in as director of the National Cancer Institute -

      Norman E. “Ned” Sharpless, M.D., becomes the 15th director of the National Cancer Institute (NCI). He comes to NCI from the University of North Carolina School of Medicine, where he was director of the Lineberger Comprehensive Cancer Center.

    3. NCI-funded TMIST study compares 2-D and 3-D mammography for finding breast cancers -

      TMIST, the first randomized trial comparing two types of digital mammography for breast cancer screening, is enrolling participants. Developed by ECOG-ACRIN and NCI, the trial is comparing 2-D and 3-D mammography for finding breast cancers.

    4. NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award -

      Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of HPV vaccines.

    5. NCI study identifies essential genes for cancer immunotherapy -

      A new NCI study identifies genes in cancer cells that are necessary for them to be killed by T cells, and therefore could be partially responsible for why immunotherapy doesn’t work in some patients.

    6. NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome -

      A new NCI study demonstrates the feasibility of a comprehensive screening protocol for patients with Li-Fraumeni syndrome, a rare inherited disorder that leads to a higher risk of developing certain cancers.

    7. NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers -

      The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations.

    8. TCGA study of liver cancer reveals potential targets for therapy -

      Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumors—including mutations in tumor-suppressing genes and high expression of immune checkpoint genes—that could be targets for drugs that already exist.

    9. Study estimates number of U.S. women living with metastatic breast cancer -

      A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population and improvements in treatment.

    10. Annual Report to the Nation: Cancer death rates continue to decline -

      According to the latest Annual Report to the Nation on the Status of Cancer, 1975-2014, overall cancer death rates continue to decrease in men, women, and children for all major racial and ethnic groups. But more work remains for some cancers.

    Next Page »